LivaNova PLC (LIVN)

Market Cap	2.40B
Revenue (ttm)	1.28B
Net Income (ttm)	-222.15M
Shares Out	54.53M
EPS (ttm)	-4.09
PE Ratio	n/a
Forward PE	11.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	571,353
Open	44.14
Previous Close	44.33
Day's Range	43.60 - 45.04
52-Week Range	32.48 - 57.35
Beta	0.91
Analysts	Strong Buy
Price Target	59.29 (+34.84%)
Earnings Date	Aug 6, 2025

About LIVN

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connect...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 2,900
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN
• Website: https://www.livanova.com

Financial Performance

In 2024, LivaNova's revenue was $1.25 billion, an increase of 8.66% compared to the previous year's $1.15 billion. Earnings were $63.23 million, an increase of 260.39%.

Analyst Summary

According to 7 analysts, the average rating for LIVN stock is "Strong Buy." The 12-month stock price target is $59.29, which is an increase of 34.84% from the latest price.

Price Target

$59.29

(34.84% upside)

Analyst Consensus: Strong Buy